Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 960 of 1,261
  1. US 7968726

    Methods of preparing imidazole-based bicyclic compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  2. US 7968664

    Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  3. US 7968615

    Polymerizable monomer, polymerizable composition and dental material

    Kuraray Medical Inc. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  4. US 7968511

    Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  5. US 7968298

    Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit CCR5-tropic HIV-1 infection and replication

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  6. US 7968115

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  7. US 7968080

    Somatostatin analogs with inhibitory activity to growth hormone release

    The Regents of the University of California · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  8. US 7968714

    Optical determination of glucose utilizing boronic acid adducts

    The Regents of the University of California · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  9. US 7968749

    Process for preparing and drying solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  10. US 7968559

    Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  11. EP 2336066

    Spule mit darauf aufgewickelter beschichteter Folienbahn

    ACINO AG [DE] · Granted Jun 22, 2011 · Expires Jun 17, 2031

    granted
  12. US 7964559

    MVL, an antiviral protein from a cyanobacterium

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  13. US 7964591

    Pyridazine derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  14. US 7964748

    Process for preparing intermediates of HMG-CoA reductase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  15. US 7964576

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  16. US 7964561

    Protein formulations for use at elevated temperatures

    Advanced Technologies and Regenerative Medicine, LLC · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  17. US 7964615

    Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor

    Almirall, S.A. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  18. US 7964646

    3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

    Pharmacopeia Drug Discovery, Inc. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  19. US 7964712

    Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains

    The Regents of the University of California · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  20. US 7964624

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  21. US 7964702

    Phalloidin derivatives and methods for their synthesis

    The Regents of the University of California · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  22. US 7964730

    Amino-substituted ethylamino β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  23. US 7964710

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted
  24. US 7964217

    Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor

    Nektar Therapeutics · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.